Testing effectiveness (Phase 2)Study completedNCT02831257
What this trial is testing
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Who this might be right for
Neurofibromatosis 2Meningioma
Massachusetts General Hospital 18
Showing 6 of 6 results